The Pharma Perspective: Selecting and Managing Your CMO Network
With insights from over 50 individuals within the Pharma industry, and accompanied by commentary from Ulrich Ruemenapp, Head of Launch Preparation, Bayer this report will take an in-depth look at the most important components when selecting a CMO, the greatest risks when choosing to outsource and best practises for managing CMO networks.
This report will explore:
- Which Key elements you need to prioritise to allow you to reduce your external partner footprint
- The greatest risks when choosing to outsource
- The characteristics sponsors most value in a CMO
Please note: That all fields marked with an asterisk (*) are required.